We confirm that protein levels of TF SOX2 were induced in mutant BRAF melanoma cell lines, A375 (top) and SK-Mel28 (middle), treated with BRAFi, vemurafenib, and MEKi, PD0325901 (Figure 1A). This evidence concerns the gene BRAF and melanoma.